Alignment Healthcare, Inc.

# Signal Note: Deerfield Management Initiates $95.8M Position in Alignment Healthcare Deerfield's entry into ALHC (61.2M shares, ~4% stake) signals conviction in the Medicare Advantage operator's business model, likely tied to favorable CMS rate announcements or operational execution metrics rather than a specific therapeutic catalyst. As a healthcare multi-strategy investor, Deerfield's investment reflects confidence in ALHC's margin profile and managed care economics rather than pipeline-driven upside. Monitor for Q3 earnings revisions and 2025 MA rate guidance as near-term catalysts validating the thesis.